Macrophages and Cancer: Unlocking the Secrets of POTEE
"New research reveals how POTEE expression in macrophages influences tumor development, offering potential new targets for cancer immunotherapy."
The battle against cancer is a complex one, with the tumor microenvironment playing a crucial role in determining the disease's progression. Among the key players in this environment are macrophages, immune cells that can either promote or suppress tumor growth. Understanding how macrophages interact with cancer cells is essential for developing effective therapies.
Recent research has focused on a specific protein called POTEE, which is expressed in macrophages. While POTEE's role in cancer has been previously linked to various tumor types, its function within immune cells, particularly macrophages, has remained largely unexplored. This lack of understanding prompted scientists to investigate POTEE's expression and function in macrophages and its potential impact on tumor development.
This article delves into the findings of a new study that sheds light on POTEE's role in macrophages and how it influences the tumor microenvironment. We will explore how POTEE expression is regulated in different macrophage subtypes, its interaction with other proteins involved in cancer progression, and its potential as a therapeutic target for cancer immunotherapy.
Research Activity and Tumor Impact
Tumor-associated macrophages (TAMs) are an important part of the tumor microenvironment and help coordinate angiogenesis and extracellular-matrix remodeling. A bibliometric analysis included 926 publications on tissue-resident macrophages and cancer—598 articles and 328 reviews—from 1,433 institutions in 57 countries, across 446 journals and involving 6,369 authors; it reported an average annual publication growth rate of 13.02%. Separately, single-cell RNA-sequencing analysis across cancers reported expansion of SPP1+ TAMs in hypoxia and their promotion of cancer malignancy. The CDC says cancer data are used to track rates and trends, support research, measure prevention and control progress, address disparities, and improve outcomes.
Studying Macrophages in Cancer
One protocol describes assessing macrophage-mediated cancer-cell phagocytosis in vitro and in vivo. It uses macrophage–cancer-cell co-culture, flow cytometry and confocal microscopy for in vitro assays, and a xenograft mouse model for in vivo detection. A central limitation noted in a review is the challenge of isolating TAMs to study their function in human cancers, motivating the search for alternatives. Reviews also describe progress in evaluating macrophages’ associations with prognosis and therapy sensitivity and in modulating their behavior in patients.
POTEE: A Key Regulator in Macrophages
The study's findings reveal that POTEE is specifically expressed in macrophages, but not in other immune cells like monocytes or T-cells. This selective expression suggests a unique role for POTEE in macrophage function. Further investigation showed that POTEE expression remains relatively stable in different macrophage subtypes (M1 and M2), regardless of various stressors, except under hypoxic conditions mimicking the tumor environment.
- Increased POTEE Expression: Hypoxia and tumor-secreted factors upregulate POTEE in macrophages.
- TAM Characteristics: Increased POTEE expression correlates with macrophages adopting a tumor-promoting phenotype.
- mTORC2 Activation: POTEE interacts with mTORC2, a key signaling pathway involved in cell growth and survival.
POTEE and Macrophage-Targeted Research
A breast-cancer study reports that POTEE promotes cancer-cell malignancy by inducing invadopodia formation through activation of SUMOylated Rac1, a small GTPase implicated in cancer progression and poor prognosis in various tumor types. In a separate study of SIRPα-ablated, induced-pluripotent-stem-cell-derived macrophages, SIRPA knockout was associated with lower expression of POTEE and several genes associated with an M2-TAM phenotype. Another source describes POTEE as a chromosome 2 paralog with N-terminal cysteine-rich domains, seven ankyrin repeats, and C-terminal spectrin-like helices. A 2025 review surveys TAM biology and macrophage-targeted therapies that may complement or enhance existing cancer-treatment strategies.
Macrophages’ Context-Dependent Roles
Macrophages can develop into different subsets in response to activating stimuli, including classically activated M1 and alternatively activated forms. A 2015 review describes TAMs as key regulators of immune–cancer interactions and says that in many settings they fuel tumor progression and negatively affect responses to therapy. At the same time, a review emphasizes that the mechanisms governing macrophage plasticity and polarization remain insufficiently understood. The sources therefore point to both the importance of TAMs in cancer and unresolved questions about how their states and effects are regulated.
Implications and Future Directions
This research provides valuable insights into the role of POTEE in macrophage function and its contribution to the tumor microenvironment. The finding that POTEE expression is upregulated under hypoxic conditions and promotes TAM characteristics suggests that targeting POTEE could be a promising strategy for cancer immunotherapy.
Macrophages as Therapeutic Targets
Macrophages have context-dependent effects in cancer, and the specific mechanisms underlying their plasticity and polarization remain insufficiently understood. A review describes how macrophage origins, polarization, functional diversity, and pathways regulating TAM-mediated immune responses shape this complex biology. When appropriately activated, macrophages can phagocytose cancer cells, kill tumor cells, and interact bidirectionally with innate and adaptive immune-system components. These capabilities have made macrophages therapeutic targets in cancer research.
A Changing Tumor Environment
Within tumor tissue, macrophages can foster tumor development, invasion, and metastasis. Their phenotype is pliable and depends on signals from the surrounding microenvironment, so macrophages co-evolve with malignant and other non-malignant cells during cancer progression. Reviews discuss the clinical relevance of macrophages to prognosis and sensitivity to therapy, as well as efforts to modulate their behavior in patients. This context dependence is a challenge for understanding and targeting macrophages across cancers.
Macrophages’ Role in Tissue Health
A report on a study describes macrophages as immune cells that clear damaged and dead cells from the body. It presents this clearance process as important for maintaining tissue health and preventing inflammation. The report also frames the study around tumors’ ability to hijack macrophages after they clear dead cells. This finding highlights how a process that normally supports tissue maintenance may intersect with cancer.
By inhibiting POTEE expression or disrupting its interaction with mTORC2, it may be possible to reprogram macrophages from tumor-promoting to tumor-suppressing cells. This approach could potentially disrupt tumor growth, prevent metastasis, and enhance the efficacy of existing cancer therapies.
Further research is needed to fully elucidate the mechanisms by which POTEE regulates macrophage function and its interaction with the tumor microenvironment. Clinical trials are also necessary to evaluate the safety and efficacy of POTEE-targeted therapies in cancer patients. Nevertheless, this study provides a solid foundation for future investigations and highlights the potential of POTEE as a novel target for cancer immunotherapy.